Pancreatic cancer has one of the lowest survival rates of any common cancers

Pancreatic cancer has one of the lowest survival rates of any common cancers

Only 3% of those diagnosed expected to live 5+ years. Mainly due to the lack of symptoms and late diagnosis. Disease has already spread to other parts of the body, with minimal options for treatment. The study from Queen Mary University conducted research, which was funded by the Pancreatic Cancer Research Fund. Published in Clinical Cancer Research, scientists discovered a new biomarker (set of three proteins) which is a potential for new diagnostic test that could detect early-stage pancreatic cancer. Could be a definitive indication of whether someone has pancreatic cancer, or doesn’t

Read More

Signs and Symptoms of Pancreatic Cancer

Signs and Symptoms of Pancreatic Cancer

Pancreatic cancer occurs in the pancreas. In the U.S. in 2015, it’s estimated that about 48,960 people will be diagnosed with pancreatic cancer, and about 40,560 people will die of pancreatic cancer, according to the American Cancer Society. Pancreatic cancer accounts for about 3 percent of all cancer cases, and about 7 percent of cancer deaths.

Read More

Promise Seen in Pancreatic Cancer through Immunotherapy

Promise Seen in Pancreatic Cancer through Immunotherapy

Pancreatic cancer advances have been making recent news, largely through the revolution that is personalized medicine, specifically immunotherapy. The statistics on pancreatic cancer are grim. Almost 50,000 people will be diagnosed in the US this year, with more than 40,000 dying from the disease. There exists no effective screening method. The disease is asymptomatic early on and spreads rapidly to other organs.

Read More

New class of compounds shrinks Pancreatic Cancer Tumors, Prevents Growth

New class of compounds shrinks Pancreatic Cancer Tumors, Prevents Growth

Scientists from University College Londonhave designed a chemical compound that has reduced the growth of pancreatic cancer tumors by 80 percent in treated mice. Published in Nature Scientific Reports. Study was funded by the UK charity, Pancreatic Cancer Research Fund, the UCL team, and led by professor Stephen Neidle.

Read More